1. Home
  2. ITP vs NXTS Comparison

ITP vs NXTS Comparison

Compare ITP & NXTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IT Tech Packaging Inc.

ITP

IT Tech Packaging Inc.

HOLD

Current Price

$0.19

Market Cap

4.0M

ML Signal

HOLD

NXTS

Nexentis Technologies Inc. Common Stock

N/A

Current Price

$5.15

Market Cap

3.6M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
ITP
NXTS
Founded
1996
2009
Country
China
Israel
Employees
N/A
9
Industry
Paper
Agricultural Chemicals
Sector
Basic Materials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.0M
3.6M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
ITP
NXTS
Price
$0.19
$5.15
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
261.4K
42.3K
Earning Date
05-12-2026
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
1.01
N/A
EPS
N/A
N/A
Revenue
$75,837,943.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.16
$0.55
52 Week High
$0.39
$6.75

Technical Indicators

Market Signals
Indicator
ITP
NXTS
Relative Strength Index (RSI) 48.43 58.86
Support Level $0.19 $3.97
Resistance Level $0.20 $6.23
Average True Range (ATR) 0.01 0.72
MACD -0.00 0.01
Stochastic Oscillator 41.08 48.53

Price Performance

Historical Comparison
ITP
NXTS

About ITP IT Tech Packaging Inc.

IT Tech Packaging Inc is a holding company engaged in the business of paper manufacturing in China. The company operates as a producer and distributor of paper products. It is involved in the production and distribution of three categories of paper products: packing paper (corrugating medium paper), offset printing paper, and tissue paper products. It also produces digital photo paper. Its business is structured into three segments: Dongfang Paper and Tengsheng Paper, which produce offset printing paper, corrugating medium paper, and tissue paper, and Baoding Shengde, which produces face masks and digital photo paper.

About NXTS Nexentis Technologies Inc. Common Stock

Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.

Share on Social Networks: